中国卫生标准管理
中國衛生標準管理
중국위생표준관리
China Health Standard Management
2015年
27期
124-125
,共2页
高血压左室肥厚心肌缺血%缬沙坦%心脑舒通
高血壓左室肥厚心肌缺血%纈沙坦%心腦舒通
고혈압좌실비후심기결혈%힐사탄%심뇌서통
Hypertensive left ventricular hypertrophy and myocardial ischemia%Valsartan%Xinnaoshutong
目的 分析缬沙坦与心脑舒通联合治疗高血压左室肥厚心肌缺血临床疗效.方法 将110例患者分为治疗组和对照组各55例,对照组患者采取缬沙坦治疗,治疗组采取缬沙坦联合心脑舒通治疗.结果 治疗组总有效率96.4%高于对照组总有效率74.5%,治疗后血压控制优于对照组,左室肥厚较对照组降低,P<0.05.结论 缬沙坦联合心脑舒通治疗高血压左室肥厚心肌缺血效果良好.
目的 分析纈沙坦與心腦舒通聯閤治療高血壓左室肥厚心肌缺血臨床療效.方法 將110例患者分為治療組和對照組各55例,對照組患者採取纈沙坦治療,治療組採取纈沙坦聯閤心腦舒通治療.結果 治療組總有效率96.4%高于對照組總有效率74.5%,治療後血壓控製優于對照組,左室肥厚較對照組降低,P<0.05.結論 纈沙坦聯閤心腦舒通治療高血壓左室肥厚心肌缺血效果良好.
목적 분석힐사탄여심뇌서통연합치료고혈압좌실비후심기결혈림상료효.방법 장110례환자분위치료조화대조조각55례,대조조환자채취힐사탄치료,치료조채취힐사탄연합심뇌서통치료.결과 치료조총유효솔96.4%고우대조조총유효솔74.5%,치료후혈압공제우우대조조,좌실비후교대조조강저,P<0.05.결론 힐사탄연합심뇌서통치료고혈압좌실비후심기결혈효과량호.
Objective To analyze the combination treatment with valsartan and Xinnaoshutong in Hypertensive Left Ventricular Hypertrophy and Myocardial Ischemia.Methods 110 patients were divided into control group and treatment group,there were 55 patients in each group. The control group patients treated with valsartan,and the treatment group treated with valsartan and Xinnaoshutong.Results Treatment group total effectivene(96.4%)was higher than the control group'total effectivenes(96.4%). Blood pressure control was superior to the control group after treatment, left ventricular hypertrophy reduced better than the control group(P<0.05).Conclusion Valsartan and Xinnaoshutong in treatment of hypertensive left ventricular hypertrophy myocardial ischemia is good.
